Precision Endocrinology: How Genomic Testing Improves Thyroid Treatment Outcomes

Precision Endocrinology How Genomic Testing Improves Thyroid Treatment Outcomes   Introduction Precision endocrinology represents a paradigm shift in the management of thyroid disorders, grounded in an expanding body of genetic and molecular evidence. Large scale genetic studies have demonstrated that approximately 57 to 71 percent

New Frontiers in Male Hypogonadism: Are We Over-Treating Low Testosterone?

New Frontiers in Male Hypogonadism Are We Over-Treating Low Testosterone   Abstract Male hypogonadism has emerged as one of the most intensively debated topics in men’s health over the past two decades. Advances in laboratory testing, increased awareness of androgen deficiency, and widespread direct to consumer marketing have

Metformin in 2025: Still the King or Time to Step Aside?

Metformin in 2025: Still the King or Time to Step Aside?   Abstract Metformin has reigned as the first-line therapeutic option for type 2 diabetes mellitus for over six decades, earning its moniker as the “king” of anti-diabetic medications. As we advance through 2025, the diabetes

Is Type 2 Diabetes Reversible? New Research Challenges Medical Consensus

Is Type 2 Diabetes Reversible? New Research Challenges Medical Consensus   Introduction The concept of type 2 diabetes reversibility represents a profound shift in the understanding and management of a condition long regarded as chronic and progressive. Diabetes remains a major global health burden, with prevalence

The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy?

The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy?   Abstract The development of tirzepatide, a first in class dual glucose dependent insulinotropic polypeptide and glucagon like peptide 1 receptor agonist, represents a potentially transformative advance in the management of type 2 diabetes and obesity. By simultaneously targeting

The Endocrine Disruptor Epidemic: What Should Clinicians Be Telling Patients?

The Endocrine Disruptor Epidemic: What Should Clinicians Be Telling Patients? Abstract Endocrine disrupting chemicals represent a growing public health concern that requires heightened awareness and engagement from healthcare professionals across disciplines. These substances, which include both synthetic and naturally occurring compounds, have the capacity

Obesity Medications: Should Family Practice Physicians Prescribe More Aggressively?

Obesity Medications Should Family Practice Physicians Prescribe More Aggressively  Check out our extensive video library (see channel for our latest videos) Abstract Obesity has escalated into a global public health crisis, affecting more than 650 million adults and contributing markedly to morbidity, mortality, and healthcare

Radioligand Therapy Results: New Evidence in Treating Neuroendocrine Tumors

Radioligand Therapy Results New Evidence in Treating Neuroendocrine Tumors  Check out our extensive video library (see channel for our latest videos) Introduction Radioligand therapies have emerged as an important breakthrough in the management of neuroendocrine tumors, a group of heterogeneous neoplasms known

Ketogenic Diets in Neurology and Endocrinology: Friend or Fad?

Ketogenic Diets in Neurology and Endocrinology: Friend or Fad?  Abstract The ketogenic diet (KD), defined by a high fat, moderate protein, and very low carbohydrate composition, has undergone a notable resurgence in both clinical practice and popular health discourse. Initially introduced in the 1920s as

Hidden Links: How Gut Microbiome Triggers Chronic Inflammation in Disease

Hidden Links: How Gut Microbiome Triggers Chronic Inflammation in Disease   Introduction The gut microbiome and inflammation share intricate connections that profoundly impact human health. Often called the “forgotten organ,” the gut microbiota plays critical roles in training and developing major components of the

Precision Endocrinology: How Genomic Testing Improves Thyroid Treatment Outcomes